Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 95 | 45 | 43 | 27 | 89 |
| Gross Profit | 95 | 45 | 43 | 27 | 89 |
| Operating Expenses | 5,272 | 3,334 | 3,252 | 4,663 | 3,604 |
| Operating Income | -5,176 | -3,289 | -3,209 | -4,636 | -3,515 |
| Other Income | 100 | 18 | -19 | -23 | -38 |
| Pre-tax Income | -5,076 | -3,271 | -3,228 | -4,658 | -3,553 |
| Income Tax | 9 | 2 | -1 | 5 | 4 |
| Net Income Continuous | -5,085 | -3,273 | -3,227 | -4,664 | -3,557 |
| Net Income | $-5,085 | $-3,273 | $-3,227 | $-4,664 | $-3,557 |
| EPS Basic Total Ops | -0.43 | -0.28 | -0.18 | -0.39 | -0.30 |
| EPS Basic Continuous Ops | -0.43 | -0.28 | -0.17 | -0.39 | -0.30 |
| EPS Diluted Total Ops | -0.43 | -0.28 | -0.18 | -0.39 | -0.30 |
| EPS Diluted Continuous Ops | -0.43 | -0.28 | -0.17 | -0.39 | -0.30 |
| EBITDA(a) | $-5,156 | $-3,280 | $-3,203 | $-4,632 | $-3,512 |